The present invention relates to compounds represented by formula (I) or composition comprising at least one of such compounds, which are inhibitors of histone deacetylase. The detailed description of these compounds is disclosed in the Description. These compounds and the composition comprising the same may be useful as medicaments for the treatment of proliferative disorders as well as other diseases involving, relating to or associated with enzymes having histone deacetylase (HDAC) activities.
本发明涉及式(I)代表的化合物或包含至少一种此类化合物的组合物,它们是组蛋白
去乙酰化酶的
抑制剂。这些化合物的详细描述见说明书。这些化合物和包含这些化合物的组合物可用作治疗增殖性疾病以及其他涉及、与具有组蛋白
去乙酰化酶(H
DAC)活性的酶有关或相关的疾病的药物。